EUVIMEDEUVIMED entdecken
Crossref

Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy

Jianping Chen, Jiahao Pan, Sijia Liu, Yangning Zhang, Suinan Sha, Haoyan Guo, Xuejiao Wang, Xiangrong Hao, Houwang Zhou, Sijian Tao, Ying Wang iD, Jun-Bing Fan iD

Advanced Materials · 2023-11 · 35 (45)

DOI: 10.1002/adma.202304187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 08.10.2023. Verfasst von Jianping Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 51…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing solid‐nanoparticle‐based drug delivery systems remain a great challenge for glioblastoma chemotherapy due to their poor capacities in crossing the blood–brain barrier/blood–brain tumor barrier (BBB/BBTB). Herein, fruit‐derived extracellular‐vesicle (EV)‐engineered structural droplet drugs (ESDDs) are demonstrated by programming the self‐assembly of fruit‐derived EVs at the DOX@squalene–PBS interface, greatly enhancing the antitumor efficacy against glioblastoma. The ESDDs experience a flexible delivery via deformation‐amplified macropinocytosis and membrane fusion, enabling them to highly efficiently cross the BBB/BBTB and deeply penetrate glioblastoma tissues. As expected, the ESDDs exhibit approximately 2.5‐fold intracellular uptake, 2.2‐fold transcytosis, and fivefold membrane fusion higher than cRGD‐modified EVs (REs), allowing highly efficient accumulation, deep penetration, and cellular internalization into the glioblastoma tissues, and thereby significantly extending the survival time of glioblastoma mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsMiceAnimalsPharmaceutical PreparationsFruitDrug Delivery SystemsBlood-Brain BarrierCell Line, Tumor

Stichwörter der Autor:innen

deformabilityextracellular vesiclesglioblastoma chemotherapystructural droplet drugs

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, P. R. China.
  • Department of Radiotherapy, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, Guangdong, 511518, P. R. China.

ORCID-Profile: Ying Wang, Jun-Bing Fan

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Chen, J., Pan, J., Liu, S., Zhang, Y., Sha, S., Guo, H., Wang, X., Hao, X., Zhou, H., Tao, S., Wang, Y., & Fan, J. B. (2023). Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy. Advanced Materials, 35(45). https://doi.org/10.1002/adma.202304187

Vancouver

Chen J, Pan J, Liu S, Zhang Y, Sha S, Guo H, et al. Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy. Advanced Materials. 2023;35(45). doi:10.1002/adma.202304187

BibTeX
@article{Chen2023,
  author = {Chen, Jianping and Pan, Jiahao and Liu, Sijia and Zhang, Yangning and Sha, Suinan and Guo, Haoyan and Wang, Xuejiao and Hao, Xiangrong and Zhou, Houwang and Tao, Sijian and Wang, Ying and Fan, Jun-Bing},
  title = {Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {45},
  doi = {10.1002/adma.202304187}
}
Kostenlos starten →